1 minute read
Grant Income(cont)
Dr Kak-Ming Ling Investigating bacteriophage behaviour and efficacy in the Cystic Fibrosis (CF) lung microenvironment
Dr Katherine Landwehr
The impact of heatedtobacco-product use on gene expression in the lung - are they really a better alternative to cigarette smoking?
Dr Kathryn Ramsey Improving prognosis and quality of life in children with muco-obstructive lung disease
Dr Samuel Montgomery Repurposing antiinflammatory drugs to tackle viral-induced exacerbations in children with cystic fibrosis
Dr Pamela Laird A programme to improve medical follow-up and health outcomes for First Nations children hospitalised with lung infections
Prof. Stephen Stick Close encounters of the nasal mucosa: identifying mechanisms that determine host responses to infection in children following first contact with respiratory viral pathogens
Dr Daniel Laucirica Assessing antiinflammatory and neutrophil-modulating capacity of phage therapy for Pseudomonas aeruginosa infection
Anthony Kicic Making bacteriophage a reality: implementation of a novel treatment pipeline for antimicrobialresistant infections
Vertex Cystic Fibrosis Research Innovation Award- Mentored
Fibrosis Innovation Grant
TPCHRF)
Innovation Australia
Prof P Le Souef Reducing the impact of climate change on the health and well-being of children in WA.
Iosifidis, Garratt, Caparros-Martin, Amenyogbe, Jones, Looi, AgudeloRomero, Martino, Starcevich, Montgomery, McDonnell, Foley, Pretorius, Evans, Pillow, Kicic, Stick, Kollmann
AgudeloRomero, Amenyogbe, Pickering, Ling, Martin, Floreani, Jones, Armitage, Elaskalani, Martino, Caparros-Martin, Aya-Bonilla, Barnett, Drouart, Breen, Buckberry, Malinge, Stick, Kicic, Verhasselt, McDonnell, Endersby
Securing a biobank to study the health implications of circadian rhythm disruption in early life
Child Research Fund (Round 10)
Collaboration Awards
Ensuring sustainable capacity in Bioinformatics at Telethon Kids Institute.
Awards
Prof Peter Le Souef What codes the development of asthma in children?
